Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Subjects
2.3. Variables Analyzed
- Catheter-related variables: Type, including short peripheral catheter (SPC), peripherally inserted central catheter (PICC) or centrally inserted central catheter (CICC), duration of catheterization (catheter dwell time was calculated using recorded insertion and removal dates), type of perfusion administered (pH and osmolarity), the number of catheters inserted and incident complications related to the catheter during the study period: loss of puncture site, extravasation, accidental removal/dislodgement, phlebitis, obstruction, non-patency, or bacteremia.
- Descriptive variables of the patient: Age, sex, medical service that treated the patient (internal medicine, general surgery, traumatology, neurology, cardiology, pulmonology, urology, and geriatrics), and hospitalization days.
- Descriptive variables of the nurse: Age, sex, years of professional practice, autonomy regarding the choice of the catheter, participation in a training program on venous catheters. Participation in a training program referred specifically to the Flebitis Zero program, a patient-safety initiative focused on improving venous catheter management and reducing catheter-related complications through standardized training and evidence-based recommendations [21]. Autonomy in catheter selection was assessed using the following self-administered question: “Do you have autonomy to choose the type of catheter to be inserted?” with four response options: “Yes, always”; “Almost always (usually)”; “Almost never (occasionally)”; and “Never.”
2.4. Study Procedures and Data Management
2.5. Sample Size
2.6. Statistical Analysis
3. Results
3.1. Patients
3.2. Catheters
3.3. Nurses
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Public Involvement Statement
Guidelines and Standards Statement
Use of Artificial Intelligence
Acknowledgments
Conflicts of Interest
References
- Nicholson, J. Royal College of Nursing’s standards for infusion therapy: An overview. Br. J. Nurs. 2018, 27, S12–S14. [Google Scholar] [CrossRef] [PubMed]
- Gorski, L.A. A Look at 2021 Infusion Therapy Standards of Practice. Home Healthc. Now 2021, 39, 62–71. [Google Scholar] [CrossRef] [PubMed]
- van Rens, M.R.; van der Lee, R.; Spencer, T.R.; van Boxtel, T.; Barone, G.; Crocoli, A.; Pinelli, F.; Pittiruti, M.; WoCoVA Foundation; GloVANet. The NAVIGATE project: A GloVANet–WoCoVA position statement on the nomenclature for vascular access devices. J. Vasc. Access 2024. Advance online publication. [Google Scholar] [CrossRef] [PubMed]
- Infusion Nurses Society. 2021 infusion therapy standards of practice updates. J. Infus. Nurs. 2021, 44, 189–190. [Google Scholar] [CrossRef] [PubMed]
- Lulie, M.; Tadesse, A.; Tsegaye, T.; Yesuf, T.; Silamsaw, M. Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar Hospital, Northwest Ethiopia: A prospective observational study. Thromb. J. 2021, 19, 48. [Google Scholar] [CrossRef] [PubMed]
- Sociedad Española de Medicina Preventiva; Salud Pública e Higiene. Estudio EPINE-EPPS No. 30: Informe España 2023; SEMPSPH: Oviedo, Spain, 2023; Available online: https://epine.es (accessed on 1 May 2025).
- Badia, J.M.; Calbo, E.; Besoli, A.; Casas, I.; Díaz, E.; Domenech, M.; Garcia, P.M.; Gasch, O.; Giménez Hernández, M.; Horcajada, J.P.; et al. Vigilància de les Infeccions Relacionades amb L’atenció Sanitària de Catalunya (VINCat): Informe Anual 2024; Servei Català de la Salut: Barcelona, Spain, 2025; Available online: https://scientiasalut.gencat.cat/handle/11351/13925 (accessed on 1 May 2025).
- Pasalioglu, K.B.; Kaya, H. Catheter indwell time and phlebitis development during peripheral intravenous catheter administration. Pak. J. Med. Sci. 2014, 30, 725–730. [Google Scholar] [CrossRef] [PubMed]
- Maddox, R.R.; Danello, S.; Williams, C.K.; Fields, M. Intravenous infusion safety initiative: Collaboration, evidence-based best practices, and smart technology help avert high-risk adverse drug events and improve patient outcomes. In Advances in Patient Safety: New Directions and Alternative Approaches; Agency for Healthcare Research and Quality (US): Rockville, MD, USA, 2008; Volume 4, pp. 1–11. [Google Scholar]
- Urbanetto, J.S.; Peixoto, C.G.; May, T.A. Incidence of phlebitis associated with the use of peripheral intravenous catheter and following catheter removal. Rev. Lat. Am. Enferm. 2016, 24, e2746. [Google Scholar] [CrossRef] [PubMed]
- O’Grady, N.P.; Alexander, M.; Burns, L.A.; Dellinger, E.P.; Garland, J.; Heard, S.O.; Lipsett, P.A.; Masur, H.; Mermel, L.A.; Pearson, M.L.; et al. Guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis. 2011, 52, e162–e193. [Google Scholar] [CrossRef] [PubMed]
- Trautner, B.W.; Darouiche, R.O. Catheter-associated infections: Pathogenesis affects prevention. Arch. Intern. Med. 2004, 164, 842–850. [Google Scholar] [CrossRef] [PubMed]
- Rodríguez-Calero, M.A.; Fernández-Fernández, I.; Molero-Ballester, L.J.; Matamalas-Massanet, C.; Moreno-Mejías, L.; de Pedro-Gómez, J.E.; Blanco-Mavillard, I.; Morales-Asencio, J.M. Risk factors for difficult peripheral venous cannulation in hospitalized patients: Protocol for a multicentre case–control study. BMJ Open 2018, 8, e020420. [Google Scholar] [CrossRef] [PubMed]
- Armenteros-Yeguas, V.; Gárate-Echenique, L.; Tomás-López, M.A.; Cristóbal-Domínguez, E.; Moreno-de Gusmão, B.; Miranda-Serrano, E.; Moraza-Dulanto, M.I. Prevalence of difficult venous access and associated risk factors in highly complex hospitalized patients. J. Clin. Nurs. 2017, 26, 4267–4275. [Google Scholar] [CrossRef] [PubMed]
- Guggenbichler, J.P.; Assadian, O.; Boeswald, M.; Kramer, A. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials. GMS Krankenhhyg. Interdiszip. 2011, 6, 17. [Google Scholar] [CrossRef]
- Mermel, L.A. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 2000, 132, 391–402. [Google Scholar] [CrossRef] [PubMed]
- Abolfotouh, M.A.; Salam, M.; Bani-Mustafa, A.; White, D.; Balkhy, H.H. Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Ther. Clin. Risk Manag. 2014, 10, 993–1001. [Google Scholar] [CrossRef] [PubMed]
- Raygada, J.L.; Levine, D.P. Methicillin-resistant Staphylococcus aureus: A growing risk in the hospital and in the community. Am. Health Drug Benefits 2009, 2, 86–95. [Google Scholar] [PubMed]
- Nimer, N.A. Nosocomial infection and antibiotic-resistant threat in the Middle East. Infect. Drug Resist. 2022, 15, 631–639. [Google Scholar] [CrossRef] [PubMed]
- Manrique-Rodríguez, S.; Heras-Hidalgo, I.; Pernia-López, M.S.; Herranz-Alonso, A.; del Río Pisabarro, M.C.; Suárez-Mier, M.B.; Cubero-Pérez, M.A.; Viera-Rodríguez, V.; Cortés-Rey, N.; Lafuente-Cabrero, E.; et al. Standardization and chemical characterization of intravenous therapy in adult patients: A step further in medication safety. Drugs R D 2021, 21, 39–64. [Google Scholar] [CrossRef] [PubMed]
- Berga Figuerola, M.L.; Casas Rodríguez, R.; Cernuda Martínez, J.A.; Del Río, C.; Romero, J.Á.F.; Maura, Y.L.; Marabajan, M.P.; Mier, B.S.M. Proyecto Nacional Flebitis Zero. Memoria 2023; Flebitis Zero: Oviedo, Spain, 2023; ISBN 978-84-09-69494-5. Available online: https://seinav.org/wp-content/uploads/2025/05/FINAL-FLEBITIS-ZERO-INFORME-2015-2023.pdf (accessed on 1 May 2025).
- Fernández-Ruiz, M.; Carretero, A.; Díaz, D.; Fuentes, C.; González, J.I.; García-Reyne, A.; Aguado, J.M.; López-Medrano, F. Hospital-wide survey of the adequacy in the number of vascular catheters and catheter lumens. J. Hosp. Med. 2014, 9, 35–41. [Google Scholar] [CrossRef] [PubMed]
- Tiwari, M.M.; Hermsen, E.D.; Charlton, M.E.; Anderson, J.R.; Rupp, M.E. Inappropriate intravascular device use: A prospective study. J. Hosp. Infect. 2011, 78, 128–132. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Granda, M.J.; Guembe, M.; Rincón, C.; Muñoz, P.; Bouza, E. Effectiveness of a training program in compliance with recommendations for venous lines care. BMC Infect. Dis. 2015, 15, 296. [Google Scholar] [CrossRef] [PubMed]

| All, n | Adequate n, (%) | 95% CI | p-Value | |
|---|---|---|---|---|
| Service | N = 297 | n = 48 | ||
| Cardiology | 21 | 11 (52.4%) | [29.8–74.3] | <0.001 |
| Geriatrics | 16 | 7 (43.8%) | [19.8–70.1] | |
| Internal Medicine | 78 | 23 (29.5%) | [19.7–40.9] | |
| Pneumology | 20 | 3 (15.0%) | [3.2–37.9] | |
| Urology | 20 | 2 (10.0%) | [1.2–31.7] | |
| Neurology | 17 | 1 (5.9%) | [0.2–28.7] | |
| General Surgery | 69 | 1 (5.8%) | [1.6–14.2] | |
| Traumatology | 56 | 0 (0.0%) | [0.0–6.4] | |
| Admission days | N = 297 | n = 51 | ||
| ≤2 days | 84 | 18 (21.4%) | [14.0–31.3] | <0.001 |
| 2–4 days | 77 | 20 (26.0%) | [17.5–36.7] | |
| 4–6 days | 56 | 11 (19.6%) | [11.3–31.8] | |
| >6 days | 80 | 2 (2.50%) | [11.3–31.8] | |
| Medication Risk | N = 296 | n = 50 | ||
| Low risk | 73 (24.7) | 47 (64.4) | [52.3–75.3] | <0.0001 |
| High risk | 223 (75.3) | 3 (1.4) | [0.3–3.9] |
| Mixed Logistic Models | ||||
|---|---|---|---|---|
| Predictors | OD | SE | CI | p |
| (Intercept) | 0.00 | 0.00 | 0.00–0.00 | <0.001 |
| Patients | ||||
| Sex [Man] | 0.9 | 1.8 | 0.0–48.5 | 0.942 |
| Age | 1.6 | 2.0 | 0.1–18.7 | 0.727 |
| Nurses | ||||
| Sex [Man] | 0.1 | 0.5 | 0.0–559.6 | 0.620 |
| Age | 1.4 | 1.2 | 0.3–7.6 | 0.718 |
| Years of Experience | 0.9 | 0.2 | 0.7–1.3 | 0.630 |
| Training [Yes] | 1.8 | 2.3 | 0.2–21.0 | 0.637 |
| Random Effects | ||||
| σ2 | 3.3 | |||
| τ00 Patient ID | 1180.4 | |||
| τ00 Service | 4.4 | |||
| ICC | 1.0 | |||
| N Patient ID | 157 | |||
| N service | 8 | |||
| Observations | 264 | |||
| Marginal R2/Conditional R2 | 0.001/0.997 | |||
| AIC | 139.0 | |||
| Nurses’ Characteristics | ||
|---|---|---|
| N = 74 | n, (SE) | Median, [Q1; Q3] |
| Sex (n = 68) | ||
| Woman | 59 (86.8%) | |
| Man | 9 (13.2%) | |
| Age (n = 69) | 37.9 (9.0) | 37.0 [30.0; 44.0] |
| Years of experience (n = 69) | 9.5 (6.8) | 10.2 [3.6; 13.8] |
| Participation in a training program (n = 74) | ||
| Yes | 17 (23.0%) | |
| No | 57 (77.0%) | |
| Nurses’ Adequacy Rate | ||||
|---|---|---|---|---|
| Predictors | Incidence Rate | SE | CI | p-Value |
| (Intercept) | 0.2 | 0.1 | 0.0–0.8 | 0.932 |
| Sex [man] | 1.3 | 0.5 | 0.6–2.5 | 0.242 |
| Age | 1.0 | 0.0 | 0.9–1.0 | 0.347 |
| Years of experience | 1.1 | 0.0 | 1.0–1.1 | 0.622 |
| Training [Yes] | 0.9 | 0.3 | 0.5–1.6 | 0.976 |
| Observations | 68 | |||
| R2 Nagelkerke | 0.124 | |||
| AIC | 148.2 | |||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Moreno-Rubio, E.; Pérez-López, C.; Carmezim, J.; Blancas-Altabella, D.; Simonetti, A.F.; Serda Sanchez, S.; Rodríguez-Molinero, A. Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study. Nurs. Rep. 2026, 16, 76. https://doi.org/10.3390/nursrep16020076
Moreno-Rubio E, Pérez-López C, Carmezim J, Blancas-Altabella D, Simonetti AF, Serda Sanchez S, Rodríguez-Molinero A. Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study. Nursing Reports. 2026; 16(2):76. https://doi.org/10.3390/nursrep16020076
Chicago/Turabian StyleMoreno-Rubio, Esther, Carlos Pérez-López, João Carmezim, David Blancas-Altabella, Antonella F. Simonetti, Silvia Serda Sanchez, and Alejandro Rodríguez-Molinero. 2026. "Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study" Nursing Reports 16, no. 2: 76. https://doi.org/10.3390/nursrep16020076
APA StyleMoreno-Rubio, E., Pérez-López, C., Carmezim, J., Blancas-Altabella, D., Simonetti, A. F., Serda Sanchez, S., & Rodríguez-Molinero, A. (2026). Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study. Nursing Reports, 16(2), 76. https://doi.org/10.3390/nursrep16020076

